More about Cera Sanitaryware Limited
Fundamentals for Cera Sanitaryware Limited
Regulatory Filings for Cera Sanitaryware Limited
Defence Profits Reach Dharavi's Machinists
From COVID Debt to Green Despair: Industrial Discharge Is Destroying India’s Last Prawn Nurseries
The Hidden Cost of India's Electronics Assembly Push: A 40% E-Waste Surge and the Death of Affordable Repair
The Wedding Loan Trap: How India’s Microfinance Boom Turned Housewives Into Ghost Borrowers and Temple Brass Into EMI Cash
Fundamentals for Cera Sanitaryware Limited
Business Operations:
Sector: IndustrialsIndustry: Building Products & Equipment
Cera Sanitaryware Limited provides sanitary ware and faucet ware products in India. The company offers sanitaryware comprising EWC's, wash basins, urinals, cisterns, squatting pans, and special need accessories. It also offers faucets, showers, auxiliaries, health faucets, and bath accessories. In addition, the company provides standing bath tub, air and water massage bath tub, drop-in bath tub, shower rooms and bath tubs, shower partitions and panels, mirrors, and bath tub accessories. Further, it offers glazed, polished, ceramic wall and floor tiles; elevation and parking tiles, and slabs. The company exports its products. Cera Sanitaryware Limited was founded in 1980 and is based in Ahmedabad, India.
Revenue projections:
With CERA's revenues expected to fall below the previous year's, investors are likely to approach the stock with caution. Declining revenues can negatively affect profitability, which makes it harder for the company to maintain investor confidence and perform well in the market.
Financial Ratios:
| currentRatio | 0.000000 |
|---|---|
| forwardPE | 26.663269 |
| debtToEquity | 4.352000 |
| earningsGrowth | -0.483000 |
| revenueGrowth | 0.103000 |
| grossMargins | 0.505900 |
| operatingMargins | 0.082690 |
| trailingEps | 164.410000 |
| forwardEps | 196.150000 |
CERA's Forward PE is in a favorable range, meaning its stock price compares well with its earnings and isn't overpriced. This leaves room for growth, making it a compelling opportunity for investors looking to benefit from potential future gains.
CERA's low earnings and revenue growth suggest shrinking profits. This negative trend could indicate that the company is struggling to maintain its financial performance and may face challenges ahead.
Cera Sanitaryware Limited's negative gross and operating margins signal that the company is not profitable, struggling to cover costs associated with production and operations. This could be a red flag for its financial performance moving forward.
CERA's forward EPS exceeding its trailing EPS reflects expectations of increased profitability for the current year. This suggests that the company is projected to achieve higher earnings than in the previous financial year, signaling positive growth and improved financial health.
Price projections:
Price projections for CERA have been steadily revised downward over time, indicating growing concerns about the company's future performance. This downward trend reflects reduced optimism among analysts regarding CERA's ability to meet previous expectations.
Insider Transactions:
There were 4 transactions selling Cera Sanitaryware Limited stock, with prevailing market price of 5971.7249755859375.5 purchases of Cera Sanitaryware Limited stock were recorded, with market price of 5629.1 per share.More buys than sells near the current price levels of Cera Sanitaryware Limited might signal a favorable outlook for the stock. Investors seem to be showing confidence by purchasing more, potentially expecting positive future performance.
Recommendation changes over time:
The recent buy bias for Cera Sanitaryware Limited from analysts signals strong confidence in the stock's potential. This positive sentiment could encourage investors to see Cera Sanitaryware Limited as a smart place to invest their money, especially those looking for stable, long-term returns in a well-established company.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
From Lifesaving Drugs to Sick Units: The Hidden Energy Crisis Inside India’s Pharma Clusters
From Price Pressures to Profit Power: The MSME Playbook Redefining India’s Economy
₹90 Crore Bet Signals a Massive Shift in India’s Rural Economy